期刊文献+

健康社区人群N末端B型利钠肽原的分布特征及其影响因素 被引量:7

Plasma amino-terminal pro-brain natriuretic peptide level and affecting factors in a community-based healthy Chinese population
原文传递
导出
摘要 目的 探讨北京地区健康人群N末端B型利钠肽原(NT-proBNP)的血浆水平及其影响因素.方法 2012年3至7月入选北京社区健康人群1 034例,其中男性486例,女性548例.留取血浆标本,采用荧光免疫分析法进行NT-proBNP检测.采用经验法估计NT-proBNP的正常参考值范围,分析影响健康人NT-proBNP血浆水平的因素.结果 年龄和性别是影响健康人NT-proBNP水平的重要因素,年龄<45岁、45 ~ 54岁、55 ~ 64岁、65 ~ 74岁时,男性NT-proBNP水平均明显低于女性(P值分别为0.005、0.001、0.001、0.011),年龄≥75岁时NT-proBNP水平性别间差异无统计学意义(P =0.504).无论男性、女性,NT-proBNP水平均随年龄增长而升高.体质指数也是影响NT-proBNP水平的独立因素(P<0.001),而在一定肾功能范围内,估测肾小球滤过率并非NT-proBNP的独立影响因素.NT-proBNP参考值范围:<55岁以下人群男性<133 ng/L,女性<289 ng/L;55~ 74岁人群男性< 185 ng/L,女性<333 ng/L;≥75岁人群男性<465 ng/L,女性<378 ng/L.结论 影响北京地区健康人血浆NT-proBNP水平的主要因素为年龄、性别和体质指数,根据这些因素探讨人群NT-proBNP参考值范围具有重要价值. Objective To investigate the plasma level of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and related influencing factors in a community-based healthy population in Beijing area.Methods We measured plasma NT-proBNP level by fluoroimmunoassay between March 2012 and July 2012 from 1 034 healthy subjects (including 486 men and 548 women).Empiric method was used to determine the reference value and influencing factors were analyzed.Results Age and gender are important factors affecting the level of NT-proBNP in healthy subjects.NT-proBNP plasma level is significantly higher in women than in men within each age strata below 75 years old,i.e.〈45,45-54,55-64 and 65-74 years old (P =0.005,0.001,0.001,0.011 respectively),but NT-proBNP plasma level is similar between male and female older than 75 years (P =0.504).NT-proBNP level also increases with age irrespective of gender.Body mass index (BMI) is another independent influencing factor of NT-proBNP (P 〈0.001),while estimated glomerular filtration rate is not influencing factor.The reference range of NT-proBNP is 〈133 ng/L for men and 〈289 ng/L for women aged 〈55 years old,〈 185 ng/L for men and 〈333 ng/L for women aged between 55 and 64 years old,and 〈465 ng/L for men and 〈378 ng/L for women aged ≥75 years old.Conclusion The major influencing factors of NT-proBNP level in the healthy population are age,gender and BMI.It essential to establish normal reference range of NT-proBNP according to these factors for Chinese population.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2015年第6期511-515,共5页 Chinese Journal of Cardiology
关键词 利钠肽 参考值 Natriuretic peptide,brain Reference values
  • 相关文献

参考文献9

  • 1中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122. 被引量:4652
  • 2Gansevoort RT, de Jong PE. Challenges for the present CKD classification system[ J ]. Curr Opin Nephrol Hypertens, 2010, 19 (3) :308-314.
  • 3潘柏申,蔡乃绳,李清,范维琥,李勇,郭玮,周琰,陶青.表面健康人群氨基末端B型利钠肽参考范围调查[J].中华检验医学杂志,2006,29(1):23-26. 被引量:66
  • 4Costello-Boerrigter LC, Boerrigter G, Redfield MM, et al. Amino- terminal pro-B-type natriuretic peptide and B-type natriuretic pepfide in the general community: determinants and detection of left ventricular dysfunction [ J]. J Am Coll Cardiol, 2006, 47 (2) : 345-353.
  • 5Fradley MG, Larson MG, Cheng S, et al. Reference limits for N- terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study) [ J]. Am J Cardiol, 2011, 108(9) :1341-1345.
  • 6Yamashita T, Kohara K, Tabara Y, et al. Muscle mass, visceral fat, and plasma levels of B-type natriuretic peptide in healthy individuals ( from the J-SHIPP Study) [J ]. Am J Cardiol, 2014, 114(4) :635-640.
  • 7韦丙奇,杨跃进,张健,张春玲,徐波,高润霖.无器质性心脏病者血浆N末端B型利钠肽原浓度及其影响因素[J].中华心血管病杂志,2009,37(9):804-808. 被引量:11
  • 8Christenson RH, Azzazy HM, Duh SH, et al. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality[ J]. Clin Chem, 2010, 56(4) :633-641.
  • 9Jafri L, Kashif W, Tai J, et al. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function [ J ]. BMC Nephrol, 2013, 14 : 117.

二级参考文献32

  • 1Bozkurt B,Mann DL. Use of biomarkers in the management of heart failure. Are we there yet? Circulation ,2003,107 : 1231-1233.
  • 2White HD,French JK. Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol,2003,42 : 1917-1920.
  • 3Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Euro Heart J,2001,22 : 1527-1560.
  • 4Hunt SA,Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation ,2005,112 :e154-e235.
  • 5de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet ,2003,362:316-322.
  • 6Yeo KTJ, Wu AHB, Apple FS, et al. Muhicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta,2003,338 : 107-115.
  • 7Vasan RS. Expanding indications for natriuretic peptides:impottance of better new (research) protocols. Am Heart J ,2004,148:743-746.
  • 8Panteghini M,Pagani F,Yeo KTJ,et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem,2004,50:327-332.
  • 9Jaffe AS, Katus H. Acute coronary syndrome biomarkers: the need for more adequate reporting. Circulation ,2004,110 : 104-106.
  • 10Redfield MM, Rodeheffer R J, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration : impact of age and gender. J Am Coll Cardiol,2002 ,40 :976-982.

共引文献4724

同被引文献82

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部